Tower Research Capital (TRC)’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-9,938
| Closed | -$40K | – | 4440 |
|
|
2019
Q4 | $40K | Buy |
+9,938
| New | +$40K | ﹤0.01% | 1480 |
|
|
2019
Q3 | – | Sell |
-187
| Closed | -$1K | – | 4799 |
|
|
2019
Q2 | $1K | Sell |
187
-1,802
| -91% | -$9.64K | ﹤0.01% | 3567 |
|
|
2019
Q1 | $12K | Buy |
+1,989
| New | +$12K | ﹤0.01% | 2613 |
|
|
2018
Q3 | – | Sell |
-5,700
| Closed | -$146K | – | 4501 |
|
|
2018
Q2 | $146K | Buy |
5,700
+704
| +14% | +$18K | 0.01% | 1211 |
|
|
2018
Q1 | $101K | Buy |
4,996
+4,791
| +2,337% | +$96.9K | 0.01% | 1254 |
|
|
2017
Q4 | $4K | Sell |
205
-5,505
| -96% | -$107K | ﹤0.01% | 3036 |
|
|
2017
Q3 | $118K | Buy |
+5,710
| New | +$118K | 0.01% | 1199 |
|
|
2017
Q2 | – | Sell |
-100
| Closed | -$2K | – | 3936 |
|
|
2017
Q1 | $2K | Sell |
100
-5,679
| -98% | -$114K | ﹤0.01% | 2719 |
|
|
2016
Q4 | $72K | Sell |
5,779
-1,663
| -22% | -$20.7K | 0.01% | 1172 |
|
|
2016
Q3 | $208K | Buy |
7,442
+3,241
| +77% | +$90.6K | 0.02% | 461 |
|
|
2016
Q2 | $147K | Buy |
4,201
+4,168
| +12,630% | +$146K | 0.01% | 869 |
|
|
2016
Q1 | $1K | Sell |
33
-758
| -96% | -$23K | ﹤0.01% | 3897 |
|
|
2015
Q4 | $27K | Buy |
791
+552
| +231% | +$18.8K | ﹤0.01% | 999 |
|
|
2015
Q3 | $7K | Buy |
+239
| New | +$7K | ﹤0.01% | 2600 |
|
|
2015
Q2 | – | Sell |
-5,444
| Closed | -$188K | – | 5363 |
|
|
2015
Q1 | $188K | Buy |
5,444
+5,244
| +2,622% | +$181K | 0.02% | 449 |
|
|
2014
Q4 | $5K | Buy |
+200
| New | +$5K | ﹤0.01% | 2778 |
|